Is hydroxyzine still prescribed?

Is Hydroxyzine Still Prescribed?

Yes, hydroxyzine remains actively prescribed in clinical practice, though its use has evolved toward more limited, specific indications rather than as a first-line agent for most conditions.

Current Clinical Use

Hydroxyzine continues to be prescribed across multiple clinical contexts, supported by both guideline recommendations and ongoing clinical research:

Primary Indications

For urticaria and pruritus, hydroxyzine maintains a defined role as an adjunctive nighttime sedating antihistamine rather than monotherapy. The British Association of Dermatologists guidelines recommend adding a sedating antihistamine at night (hydroxyzine 10-50 mg) to a non-sedating antihistamine during the day to help patients sleep better, though this provides little additional antipruritic effect if H1 receptors are already saturated 1. However, sedative antihistamines are recommended in generalized pruritus of unknown origin only in short-term or palliative settings 1.

For anxiety disorders, hydroxyzine demonstrated efficacy in a 3-month double-blind trial for generalized anxiety disorder, showing statistically significant improvement over placebo (mean HAM-A score change -12.16 vs -9.64, p=0.019) with comparable efficacy to bromazepam 2.

For perioperative use, recent evidence shows hydroxyzine 25 mg significantly reduces postoperative nausea and vomiting incidence (34.8% vs 57.0% in controls, p=0.002) 3.

Important Prescribing Restrictions and Safety Concerns

Hydroxyzine is contraindicated in several critical situations that limit its use 4:

• Prolonged QT interval - absolute contraindication due to risk of QT prolongation and Torsade de Pointes 4
• Early pregnancy - specifically contraindicated as it induced fetal abnormalities in animal studies at doses above human therapeutic range 4
• Severe hepatic impairment - sedating effects are inappropriate and should be avoided 1
• Severe renal impairment - dose should be halved in moderate impairment 1

Elderly patients should not receive sedative antihistamines for pruritus in elderly skin due to risks of confusion and over-sedation (Strength of recommendation C) 1. When hydroxyzine must be used in elderly patients, start with low doses and observe closely 4.

Emerging Safety Data Raising Concerns

Recent research has identified concerning patterns that may influence future prescribing:

• Hydroxyzine became the most identified antihistamine in impaired driving investigations in 2023, surpassing diphenhydramine, with drivers exhibiting incoordination, slurred speech, and erratic driving 5
• Long-term neurodevelopmental concerns in children: Repeat prescriptions in preschool children (under age 5) showed significantly increased rates of tic disorders (OR 1.55), anxiety (OR 1.34), and conduct disturbances (OR 1.34) by age 10 compared to single prescriptions 6

Clinical Practice Shift

The prescribing pattern has shifted from monotherapy to adjunctive use. Guidelines explicitly state that "the use of sedating antihistamines as monotherapy is now less common because of concerns about reduced concentration and performance" 1. Non-sedating H1 antihistamines (fexofenadine, loratadine, cetirizine) are now preferred as first-line agents, with hydroxyzine reserved for specific situations requiring sedation 1.

Drug Interactions Requiring Caution

Hydroxyzine requires careful consideration with concomitant medications 4:

• CNS depressants (narcotics, barbiturates) - reduce dosage of concomitant agents due to potentiation
• QT-prolonging drugs (Class IA/III antiarrhythmics, certain antipsychotics, antidepressants, antibiotics) - use with caution
• Alcohol - effects may be increased

Common Pitfalls to Avoid

• Do not prescribe hydroxyzine to elderly patients with pruritus - guidelines specifically recommend against this 1
• Do not use as monotherapy for urticaria - combine with non-sedating antihistamines or use alternatives 1
• Screen for QT prolongation risk factors before prescribing, including electrolyte imbalances, heart disease, and concomitant arrhythmogenic drugs 4
• Limit duration in preschool children given emerging neurodevelopmental safety signals 6
• Warn patients about driving impairment - hydroxyzine significantly impairs psychomotor function and driving ability 5

In summary, hydroxyzine remains prescribed but occupies a narrower therapeutic niche than historically, with increasing recognition of safety concerns that favor alternative agents in many clinical scenarios.